Similar articles

• [Bladder carcinoma in a case of multiple myeloma IgG (kappa) treated with cyclophosphamide: review of literature].

  Iwabuchi A, Hohjoh H, Fujieda H, Ohyashiki J, Ohyashiki K, Toyama K. Iwabuchi A, et al. Rinsho Ketsueki. 1988 Aug;29(8):1272-6. Rinsho Ketsueki. 1988. PMID: 3144618 Review. Japanese. No abstract available.
• [Carcinoma of the urinary bladder in a patient receiving cyclophosphamide for Wegener's granuloma: a case report].

  Shiba T, Noguchi S, Yao M, Takahashi T, Shuin T, Miura T, Kinoshita Y, Kubota Y, Hosaka M. Shiba T, et al. Hinyokika Kiyo. 1991 Apr;37(4):393-6. Hinyokika Kiyo. 1991. PMID: 1891999 Review. Japanese.
• Cyclophosphamide-induced transitional cell carcinoma of bladder in lupus nephritis.

  Chow SK, Looi LM, Loh CS, Yeap SS. Chow SK, et al. Intern Med J. 2002 Mar;32(3):114-6. Intern Med J. 2002. PMID: 11885838 No abstract available.
• Invasive bladder cancer after cyclophosphamide administration for nephrotic syndrome--a case report.

  Nakamoto T, Kasaoka Y, Ikegami Y, Usui T. Nakamoto T, et al. Hiroshima J Med Sci. 2000 Jun;49(2):121-3. Hiroshima J Med Sci. 2000. PMID: 10920579
• [Urothelial carcinoma of the bladder following cyclophosphamide therapy].

  Blume B, Rabe F, Theuring F. Blume B, et al. Z Urol Nephrol. 1984 Jan;77(1):7-9. Z Urol Nephrol. 1984. PMID: 6702330 German.